AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
Dec. 12, 2025

KARL LAGERFELD AND AARK DEVELOPERS ANNOUNCE LUXURY BEACHFRONT RESIDENTIAL PROJECT ON AL MARJAN ISLAND, RAS AL KHAIMAH

EIN Presswire

fallback image
Aug. 12, 2025

Candidate lists urged to make use of the available official routes to promote their political platform

Macao Government News

fallback image
Aug. 20, 2025

KKday Launches Exclusive 2025 Shanghai Marathon Travel Package for International Runners

EIN Presswire

fallback image
Apr. 3, 2026

Global Cost of Living Rankings 2026: Bermuda Tops the List!

Merxwire

fallback image
Dec. 15, 2025

China imposes sanctions on ex-Japanese military chief over Taiwan

MENAFN

fallback image
Dec. 15, 2025

China Imposes Sanctions on EX-Japan Military Chief

MENAFN

fallback image
Dec. 4, 2025

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

GlobeNewswire, Inc.

fallback image
Dec. 3, 2025

Tims China and Tencent’s CarbonXmade Launch Innovative Eco-friendly Straw Made with Captured CO₂

GlobeNewswire, Inc.

fallback image
Aug. 15, 2025

Rental statistics for the second quarter of 2025

Macao Government News

fallback image
Aug. 15, 2025

IAM accepts applications for License for Outdoor Cafes from food and beverage establishments on a pilot basis

Macao Government News

fallback image
Dec. 9, 2025

Tims China Announces Third Quarter 2025 Financial Results

GlobeNewswire, Inc.

fallback image
Dec. 8, 2025

HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China

GlobeNewswire, Inc.

fallback image
Dec. 9, 2025

ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%

GlobeNewswire, Inc.

fallback image
Dec. 9, 2025

ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant CML-CP

GlobeNewswire, Inc.

fallback image
Dec. 9, 2025

ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment

GlobeNewswire, Inc.

fallback image
Nov. 24, 2025

Lotus Technology Reports Unaudited Third Quarter and First Nine Months 2025 Financial Results

GlobeNewswire, Inc.

fallback image
Nov. 29, 2025

Over 120 Reported Dead in Hong Kong Tragic Fire

MENAFN

fallback image
Mar. 23, 2026

Playboy Closes China Licensing Joint Venture Deal with United Trademark Group

GlobeNewswire, Inc.

fallback image
Dec. 5, 2025

Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA

GlobeNewswire, Inc.

fallback image
Apr. 1, 2026

Hong Kong Restaurants Claim Top Two Spots in Asia’s 50 Best

GlobeNewswire, Inc.

Sign up for:

Industry Report Macao

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: